WindMIL Therapeutics
closedWindMIL Therapeutics is developing cell therapies for oncology indications.
Launch date
Employees
Market cap
-
Enterprise valuation
€118—177m (Dealroom.co estimates Jun 2018.)
Princeton New Jersey (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$10.0m | Series A | ||
$32.5m | Series B | ||
| Total Funding | €38.6m | ||
Recent News about WindMIL Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.